CYCLERION THERAPEUTICS, INC. Financing Cash Flow
CYCLERION THERAPEUTICS, INC. (CYCN) reported Financing Cash Flow of $825.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-04
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $825.00K, a 40.00% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $251.00K.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $1.83M.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2023 was $5.02M, a 17224.14% increase from fiscal 2022.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2022 was $29.00K, a 99.91% decline from fiscal 2021.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2021 was $30.79M, a 9.59% increase from fiscal 2020.
- CYCLERION THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2020 was $28.09M, a 86.72% decline from fiscal 2019.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-04 | $825.00K 10-Q · filed 2026-08-04 | $1.08M derived: sum of 3 quarters · filed 2026-08-04 | $2.90M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $825.00K S-4/A · filed 2026-07-22 | $1.08M derived: sum of 2 quarters · filed 2026-07-22 | $2.90M derived: sum of 3 quarters · filed 2026-07-22 | $2.77M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $251.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | $2.08M derived: sum of 2 quarters · filed 2026-07-22 | $1.95M derived: sum of 3 quarters · filed 2026-08-04 | $3.32M S-4/A · filed 2026-07-22 |
| 2025-09-30 | $1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.70M derived: sum of 2 quarters · filed 2026-08-04 | $3.07M 10-Q · filed 2025-11-12 | $3.07M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$130.00K derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-04 | $1.25M 10-Q · filed 2026-08-04 | $1.25M derived: sum of 3 quarters · filed 2026-08-04 | $1.25M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $1.38M S-4/A · filed 2026-07-22 | $1.38M derived: sum of 2 quarters · filed 2026-07-22 | $1.38M derived: sum of 3 quarters · filed 2026-07-22 | $1.38M derived: sum of 4 quarters · filed 2026-07-22 |
| 2024-12-31 | $0.00 derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | $0.00 derived: sum of 2 quarters · filed 2026-07-22 | $0.00 derived: sum of 3 quarters · filed 2026-07-22 | $0.00 S-4/A · filed 2026-07-22 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $0.00 derived: sum of 3 quarters · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 derived: sum of 3 quarters · filed 2025-11-12 | |
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $5.02M 10-K/A · filed 2025-11-12 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $5.02M 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $5.02M 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $12.00K derived: sum of 2 quarters · filed 2024-03-05 | $29.00K derived: sum of 3 quarters · filed 2024-03-05 | $29.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $17.00K derived: sum of 2 quarters · filed 2023-11-13 | $17.00K 10-Q · filed 2023-11-13 | $102.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $17.00K 10-Q · filed 2023-07-28 | $102.00K derived: sum of 3 quarters · filed 2023-07-28 | $145.00K derived: sum of 4 quarters · filed 2023-07-28 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 | $85.00K derived: sum of 2 quarters · filed 2023-03-22 | $128.00K derived: sum of 3 quarters · filed 2023-03-22 | $30.76M derived: sum of 4 quarters · filed 2023-03-22 |
| 2021-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $128.00K derived: sum of 2 quarters · filed 2023-03-22 | $30.76M derived: sum of 3 quarters · filed 2023-03-22 | $30.79M 10-K · filed 2023-03-22 |
| 2021-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $30.67M derived: sum of 2 quarters · filed 2022-11-03 | $30.70M 10-Q · filed 2022-11-03 | $30.86M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $30.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $30.66M 10-Q · filed 2022-08-09 | $30.82M derived: sum of 3 quarters · filed 2022-08-09 | $55.08M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $27.00K 10-Q · filed 2022-05-04 | $186.00K derived: sum of 2 quarters · filed 2022-05-04 | $24.45M derived: sum of 3 quarters · filed 2022-05-04 | $28.12M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $24.43M derived: sum of 2 quarters · filed 2022-02-24 | $28.09M derived: sum of 3 quarters · filed 2022-02-24 | $28.09M 10-K · filed 2022-02-24 |
| 2020-09-30 | $24.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $27.93M derived: sum of 2 quarters · filed 2021-11-09 | $27.93M 10-Q · filed 2021-11-09 | $28.08M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $3.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $3.66M 10-Q · filed 2021-07-29 | $3.81M derived: sum of 3 quarters · filed 2021-07-29 | $4.17M derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | $1.00K 10-Q · filed 2021-04-30 | $146.00K derived: sum of 2 quarters · filed 2021-04-30 | $511.00K derived: sum of 3 quarters · filed 2021-04-30 | $175.49M derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $510.00K derived: sum of 2 quarters · filed 2021-02-25 | $175.49M derived: sum of 3 quarters · filed 2021-02-25 | $211.57M 10-K · filed 2021-02-25 |
| 2019-09-30 | $365.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $175.34M derived: sum of 2 quarters · filed 2020-11-05 | $211.43M 10-Q · filed 2020-11-05 | $236.39M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $174.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $211.06M 10-Q · filed 2020-08-03 | $236.03M derived: sum of 3 quarters · filed 2020-08-03 | $262.49M derived: sum of 4 quarters · filed 2020-08-03 |
| 2019-03-31 | $36.09M 10-Q · filed 2020-05-04 | $61.05M derived: sum of 2 quarters · filed 2020-05-04 | $87.52M derived: sum of 3 quarters · filed 2020-05-04 | $110.44M derived: sum of 4 quarters · filed 2020-05-04 |
| 2018-12-31 | $24.97M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $51.43M derived: sum of 2 quarters · filed 2020-03-12 | $74.35M derived: sum of 3 quarters · filed 2020-03-12 | $100.94M 10-K · filed 2020-03-12 |
| 2018-09-30 | $26.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $49.38M derived: sum of 2 quarters · filed 2019-11-12 | $75.97M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $22.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $49.51M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $26.59M 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |